A patient with loss of vision in the right eye and neurofibromatosis type 1 (vol 180, pg 203, 2009)

被引：0

|

作者：

Mumoli, N.

Cei, M.

Bartolomei, C.

机构：

来源：

CANADIAN MEDICAL ASSOCIATION JOURNAL | 2009年 / 180卷 / 07期

关键词：

D O I：

10.1503/cmaj.090411

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：739 / 739

页数：1

相关论文

共 50 条

[31] Technical standards and guidelines for myotonic dystrophy type 1 testing (vol 11, pg 552, 2009)
Prior, Thomas W.
GENETICS IN MEDICINE, 2016, 18 (01) : 107 - 107
[32] Novel LMF1 Nonsense Mutation in a Patient with Severe Hypertriglyceridemia (vol 94, pg 4584, 2009)
Cefalu, Angelo B.
Noto, Davide
Arpi, Maria Luisa
Yin, Fen
Spina, Rossella
Hilden, Hannele
Barbagallo, Carlo M.
Carroccio, Antonio
Tarugi, Patrizia
Squatrito, Sebastiano
Vigneri, Riccardo
Taskinen, Marja-Riitta
Peterfy, Miklos
Averna, Maurizio R.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 465 - 465
[33] Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas (vol 143, pg 1378, 2023)
不详
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (02) : 435 - 435
[34] Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases (vol 20, pg 983, 2003)
Kandt, RS
NEUROLOGIC CLINICS, 2003, 21 (04) : 982 - +
[35] Prenatal ultrasonographic prediction homozygous type 1 α-thalassemia at 12 to 13 weeks of gestation (vol 180, pg 148, 1999)
Lam, YH
Tang, MHY
Lee, CP
Tse, HY
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (04) : 1029 - 1029
[36] The anti-interleukin-1 in type 1 diabetes action trial - background and rationale (vol 25, pg 321, 2009)
Pickersgill, Linda M. S.
Mandrup-Poulsen, Thomas R.
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (08) : 780 - 780
[37] Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways (vol 6, pg 208, 2013)
Afshinnia, Farsad
Vega-Warner, Virginia
Killen, Paul
CLINICAL KIDNEY JOURNAL, 2013, 6 (03): : 364 - 364
[38] Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis (vol 88, pg 87, 2017)
Smith, M. J.
NEUROLOGY, 2017, 89 (02) : 215 - 215
[39] PROTON MR SPECTROSCOPY IN PATIENTS WITH NEUROFIBROMATOSIS TYPE-1 - EVALUATION OF HAMARTOMAS AND CLINICAL CORRELATION (VOL 16, PG 141, 1995)
CASTILLO
AMERICAN JOURNAL OF NEURORADIOLOGY, 1995, 16 (04) : 808 - 808
[40] Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1 (vol 93, pg e1076, 2020)
Ahlawat, S.
Blakeley, J. O.
Rodriguez, F. J.
Fayad, L. M.
NEUROLOGY, 2020, 94 (11) : 504 - 504

← 1 2 3 4 5 →